Draft Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022 Draft Human Medicines (Amendments Relating to the Early Access to Medicines Scheme) Regulations 2022 Debate

Full Debate: Read Full Debate
Department: Department of Health and Social Care

Draft Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2022 Draft Human Medicines (Amendments Relating to the Early Access to Medicines Scheme) Regulations 2022

Steven Bonnar Excerpts
Tuesday 8th March 2022

(2 years, 2 months ago)

General Committees
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Steven Bonnar Portrait Steven Bonnar (Coatbridge, Chryston and Bellshill) (SNP)
- Hansard - -

It is a pleasure to see you in the Chair, Ms Rees. I thank the Minister for laying out his reasons for introducing the legislation, and why it is required. I echo the comments made by the Opposition spokesperson on our gratitude to our frontline health workers in the fight against coronavirus. They are the real heroes of these nations.

The Scottish National party welcomes moves to ensure that an expanded category of authorised vaccinators who can deliver the coronavirus vaccine is maintained, and to extend the expansion of locations at which vaccines can be prepared and administered. With full authorisation of the coronavirus vaccine still pending, those moves are necessary. The fact that the conditions need to be extended, as laid out by the Minister, is a reminder to us all that the pandemic is still ongoing, and therefore a reminder to Governments that they should be taking a cautious and sensible route out of it. This is one way in which we will be able to achieve that.

Moving on to the draft Human Medicines (Amendment Relating to the Early Access to Medicines Scheme) Regulations, the SNP again welcomes moves to support more patients for whom medicines exist that are not yet authorised for full sale and marketing in the UK medical market. Approval of medicines under EAMS must be followed by the adequate provision of medicines to those who need them. As the legislation around medical marijuana shows, approval does not always translate to availability to those in need. The UK Government should take the opportunity, while reviewing medicine provision, to consider the removal of prescription fees. While people throughout the UK face the consequences of a real cost of living crisis, forcing them to pay for their medicine too is, in our opinion, wrong. I would like to hear the Minister’s opinions on that.